97 related articles for article (PubMed ID: 23098469)
21. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
[TBL] [Abstract][Full Text] [Related]
22. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
23. Medical costs of treating breast cancer among younger Medicaid beneficiaries by stage at diagnosis.
Trogdon JG; Ekwueme DU; Poehler D; Thomas CC; Reeder-Hayes K; Allaire BT
Breast Cancer Res Treat; 2017 Nov; 166(1):207-215. PubMed ID: 28702893
[TBL] [Abstract][Full Text] [Related]
24. Costs of cancer care in children and adolescents in Ontario, Canada.
de Oliveira C; Bremner KE; Liu N; Greenberg ML; Nathan PC; McBride ML; Krahn MD
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28500732
[TBL] [Abstract][Full Text] [Related]
25. A nationwide epidemiological study of newly diagnosed spine metastasis in the adult Korean population.
Sohn S; Kim J; Chung CK; Lee NR; Park E; Chang UK; Sohn MJ; Kim SH
Spine J; 2016 Aug; 16(8):937-45. PubMed ID: 26972626
[TBL] [Abstract][Full Text] [Related]
26. Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.
Jönsen A; Hjalte F; Willim M; Carlsson KS; Sjöwall C; Svenungsson E; Leonard D; Bengtsson C; Rantapää-Dahlqvist S; Pettersson S; Gunnarsson I; Zickert A; Gustafsson JT; Rönnblom L; Petersson IF; Bengtsson AA; Nived O
Semin Arthritis Rheum; 2016 Jun; 45(6):684-90. PubMed ID: 26743074
[TBL] [Abstract][Full Text] [Related]
27. The economic burden of human papillomavirus infection-associated diseases in the Republic of Korea, 2002-2015.
Ki M; Choi HY; Han M; Oh JK
Vaccine; 2018 Jul; 36(31):4633-4640. PubMed ID: 29961603
[TBL] [Abstract][Full Text] [Related]
28. [Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database].
Lim SJ; Kim HJ; Nam CM; Chang HS; Jang YH; Kim S; Kang HY
J Prev Med Public Health; 2009 Jul; 42(4):251-60. PubMed ID: 19675402
[TBL] [Abstract][Full Text] [Related]
29. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective.
Sagar B; Lin YS; Castel LD
J Med Econ; 2017 Oct; 20(10):1018-1023. PubMed ID: 28581874
[TBL] [Abstract][Full Text] [Related]
30. [Medical expenses by site of cancer and survival time among cancer patients in the last one year of life].
Yi JJ; Yoo WK; Kim SY; Kim KK; Yi SW
J Prev Med Public Health; 2005 Feb; 38(1):9-15. PubMed ID: 16312905
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and socio-economic burden of heart failure in an aging society of South Korea.
Lee H; Oh SH; Cho H; Cho HJ; Kang HY
BMC Cardiovasc Disord; 2016 Nov; 16(1):215. PubMed ID: 27832754
[TBL] [Abstract][Full Text] [Related]
32. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages.
Alexandrescu DT
Dermatol Online J; 2009 Nov; 15(11):1. PubMed ID: 19951637
[TBL] [Abstract][Full Text] [Related]
33. Mean direct medical care costs associated with cervical cancer for commercially insured patients in Texas.
Lairson DR; Fu S; Chan W; Xu L; Shelal Z; Ramondetta L
Gynecol Oncol; 2017 Apr; 145(1):108-113. PubMed ID: 28196673
[TBL] [Abstract][Full Text] [Related]
34. Incidence-based cost-of-illness model for metastatic breast cancer in the United States.
Sorensen SV; Goh JW; Pan F; Chen C; Yardley D; Martín M; Knopf K; Benedict A; Giorgetti C; Iyer S
Int J Technol Assess Health Care; 2012 Jan; 28(1):12-21. PubMed ID: 22617734
[TBL] [Abstract][Full Text] [Related]
35. Economic Burden of Osteoporosis in South Korea: Claim Data of the National Health Insurance Service from 2008 to 2011.
Ha YC; Kim HY; Jang S; Lee YK; Kim TY
Calcif Tissue Int; 2017 Dec; 101(6):623-630. PubMed ID: 28913546
[TBL] [Abstract][Full Text] [Related]
36. National estimates of medical costs incurred by nonelderly cancer patients.
Howard DH; Molinari NA; Thorpe KE
Cancer; 2004 Mar; 100(5):883-91. PubMed ID: 14983481
[No Abstract] [Full Text] [Related]
37. [Health care costs of cancer patients. Resource utilization by cancer patients].
Gundgaard J; Nielsen JN; Olsen J; Sørensen J
Ugeskr Laeger; 2002 May; 164(22):2882-5. PubMed ID: 12082814
[TBL] [Abstract][Full Text] [Related]
38. Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data.
Lang K; Lines LM; Lee DW; Korn JR; Earle CC; Menzin J
Clin Gastroenterol Hepatol; 2009 Feb; 7(2):198-204. PubMed ID: 18849013
[TBL] [Abstract][Full Text] [Related]
39. Cancer costs and outcomes for common cancer sites in the Finnish population between 2009-2014.
Torkki P; Leskelä RL; Linna M; Mäklin S; Mecklin JP; Bono P; Kataja V; Karjalainen S
Acta Oncol; 2018 Jul; 57(7):983-988. PubMed ID: 29451406
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
